Skip to content
Recall Observatory FDA recall evidence

Drug product

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

D-0451-2026

March 16, 2026

Class II

Product summary

Firm
Cipla USA, Inc.
Event
Event 98670
Status
Ongoing
Classification
Class II
Quantity
63,192 bottles
Official record key
drug-enforcement:D-0451-2026

Official wording

Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Code information: Lot, expiry: 4PB0224, exp March-2026; 4PB0505, 4PB0506, 4PB0507, exp September-2026; 5PB0564, exp April-2027

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations